Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Active not recruiting × Ropivacaine × Gynecologic × Clear all

Phase

Status

Completed 2 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Advanced Ovarian Cancer 1

Interventions

pembrolizumab 40 Paclitaxel 40 Carboplatin 37 olaparib 25 Magnetic Resonance Spectroscopy 20 Bevacizumab 20 Nivolumab 19 Specimen Handling 18 Cisplatin 18 Taxes 17 Biopsy 13 Gemcitabine 12 Cyclophosphamide 11 niraparib 10 durvalumab 10 Immunoglobulin G 9 Doxorubicin 9 Disulfides 9 dostarlimab 8 atezolizumab 8 Surveys and Questionnaires 8 Letrozole 8 Brachytherapy 8 Radiotherapy 7 liposomal doxorubicin 6 lenvatinib 6 Platinum 6 Observation 6 Docetaxel 6 fludarabine 5

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065009 2024-01-11

IPLA-OVCA

Karolinska Institutet

Phase 3 Active not recruiting

Advanced Ovarian Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡